These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2595431)

  • 1. Metoclopramide-induced parkinsonism.
    Sethi KD; Patel B; Meador KJ
    South Med J; 1989 Dec; 82(12):1581-2. PubMed ID: 2595431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoclopramide-induced parkinsonism in hemodialysis patients. Report of two cases.
    Sirota RA; Kimmel PL; Trichtinger MD; Diamond BF; Stein HD; Yudis M
    Arch Intern Med; 1986 Oct; 146(10):2070-1. PubMed ID: 3767555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse neurologic effects of metoclopramide.
    Grimes JD; Hassan MN; Preston DN
    Can Med Assoc J; 1982 Jan; 126(1):23-5. PubMed ID: 7059869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases.
    Indo T; Ando K
    Arch Neurol; 1982 Aug; 39(8):494-6. PubMed ID: 7103798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe parkinsonism due to metoclopramide: the importance of early recognition].
    de Ronde MW; Kingma HJ; Munts AG
    Ned Tijdschr Geneeskd; 2013; 157(26):A6037. PubMed ID: 23835236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide-induced parkinsonism and depression.
    Jibiki I; Maeda T; Yamaguchi N
    Acta Neurol (Napoli); 1992 Apr; 14(2):130-3. PubMed ID: 1414557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe parkinsonism due to metoclopramide in a patient with polypharmacy].
    Hoogendam A; Hofmeijer J; Frijns CJ; Heeringa M; Schouten-Tjin a Tsoi SL; Jansen PA
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):175-7. PubMed ID: 11845569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.
    Tsai SC; Sheu SY; Chien LN; Lee HC; Yuan EJ; Yuan RY
    Br J Clin Pharmacol; 2018 Sep; 84(9):2000-2009. PubMed ID: 29745438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.
    Miller LG; Jankovic J
    Arch Intern Med; 1989 Nov; 149(11):2486-92. PubMed ID: 2684075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of parkinsonism after treatment with metoclopramide].
    Ogawa N; Takayama H; Kuroda H; Ota Z; Yamamoto M
    Nihon Ronen Igakkai Zasshi; 1986 Sep; 23(5):453-6. PubMed ID: 3807025
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy.
    Grimes JD
    N Engl J Med; 1981 Dec; 305(23):1417. PubMed ID: 7300862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Four cases of metoclopramide-induced parkinsonism].
    Uchiyama F; Kamei T; Fukuyama J; Akashi T; Ohta H
    Nihon Naika Gakkai Zasshi; 1986 Apr; 75(4):533-6. PubMed ID: 3734542
    [No Abstract]   [Full Text] [Related]  

  • 13. Metoclopramide-induced parkinsonism.
    Sandyk R
    S Afr Med J; 1983 May; 63(22):838. PubMed ID: 6857398
    [No Abstract]   [Full Text] [Related]  

  • 14. Asymmetry in clinical features of drug-induced parkinsonism.
    Sethi KD; Zamrini EY
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide-induced parkinsonism and severe edema.
    Ahmad S
    South Med J; 1984 Oct; 77(10):1345. PubMed ID: 6484665
    [No Abstract]   [Full Text] [Related]  

  • 17. Metoclopramide-induced encephalopathy in Parkinson disease.
    Robottom BJ; Shulman LM; Anderson KE; Weiner WJ
    South Med J; 2010 Feb; 103(2):178-80. PubMed ID: 20065895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoclopramide-induced Parkinsonism.
    Buchholz D; Kariya S
    Arch Neurol; 1983 Aug; 40(8):528-9. PubMed ID: 6870620
    [No Abstract]   [Full Text] [Related]  

  • 19. Metoclopramide-induced parkinsonism.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1987 Jun; 10(3):287-9. PubMed ID: 2457440
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinsonism: an under-recognised complication of metoclopramide use.
    Ceylon Med J; 1996 Sep; 41(3):125. PubMed ID: 8917980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.